EU Regulatory Review Adopts Negative Opinion of Lecanemab as Treatment for Alzheimer Disease
… European Union (EU). 1. Lecanemab, a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insoluble …Read More